Andrew J. Ahmann, MD, Named American Diabetes Association’s® 2018 Outstanding Physician Clinician in Diabetes


Michelle Kirkwood

Arlington, Virginia
May 18, 2018

Andrew J. Ahmann, MD, has been selected to receive the American Diabetes Association’s® (ADA’s) 2018 Outstanding Physician Clinician in Diabetes Award. Presented annually, the award honors praiseworthy contributions to diabetes clinical practice. Dr. Ahmann will be recognized with this honor during the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando.

Dr. Ahmann is a Professor of Medicine at Oregon Health & Science University (OHSU) and Director of the Harold Schnitzer Diabetes Health Center. In 2007, he led the transformation of the OHSU diabetes clinic into a comprehensive center serving more than 5,000 individuals with diabetes of all ages and socioeconomic circumstances. Among his many contributions to the local diabetes community are long-term service as president of the ADA Leadership Council, chairing the Oregon Diabetes Guidelines Task Force and the Oregon Diabetes Coalition, and decades of volunteering as a physician to support youth while attending the ADA’s diabetes camps.

“Dr. Ahmann’s impressive local and national contributions to both our understanding of diabetes treatment and the expansion of access to treatment for communities that desperately need it have earned our gratitude and admiration,” said the ADA’s 2018 President of Health Care and Education Felicia Hill-Briggs, PhD, ABPP. “Congratulations on this honor, Dr. Ahmann, and thank you for your continued work to support all who live with and are affected by diabetes.”

Dr. Ahmann highly values training and mentorship of medical students, residents and fellows, inspiring many to pursue diabetes research and practice. Additionally, Dr. Ahmann has contributed to the ADA’s Standards of Medical Care in Diabetes, guidelines for inpatient management of hyperglycemia and guidelines on the use of diabetes technology. He has served on the ADA’s Scientific Sessions Planning Committee and on the Editorial Board of the journal Diabetes Care. Other scientific activities include numerous diabetes publications and clinical research projects, such as the ongoing Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study and the Type 1 Diabetes Exchange.  

The American Diabetes Association’s 78th Scientific Sessions, to be held June 22-26, 2018, at the Orange County Convention Center in Orlando, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, more than 16,000 health care professionals from around the world will have exclusive access to more than 3,000 original diabetes research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight theme areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Felicia Hill-Briggs, PhD, ABPP, President of Health Care and Education, will deliver her address, “The American Diabetes Association in the Era of Health Care Transformation,” on Saturday, June 23, and Jane E.B. Reusch, MD, President of Medicine and Science, will present her address, “24/7/365 – Lifetime with Diabetes,” on Sunday, June 24. In total, the 2018 Scientific Sessions includes 375 oral presentations; 2,117 poster presentations, including 47 moderated poster discussions; and 297 published-only abstracts. Join the Scientific Sessions conversation on social media using #2018ADA.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)